health claim watch

Heinz files children’s immune health claim

By Annie Harrison-Dunn contact

- Last updated on GMT

The article 14 claim reads: 'Nutrimune supports the immune defence in the gastrointestinal and upper-respiratory tract of young children.' Photo credit: iStock.com / studiodr
The article 14 claim reads: 'Nutrimune supports the immune defence in the gastrointestinal and upper-respiratory tract of young children.' Photo credit: iStock.com / studiodr
Heinz has filed a health claim for children’s gastrointestinal and upper-respiratory tract health for its product Nutrimune.

The article 14 claim reads: “Nutrimune supports the immune defence in the gastrointestinal and upper-respiratory tract of young children.”

According to the European Food Safety Authority’s (EFSA) register of questions, the application with be processed within the legal deadline for such dossiers, meaning EFSA has five months to complete its evaluation once the application is considered complete.

We contacted Heinz to learn more about the product but it did not respond to our request for comment in time for the publication of this article.

Article 14 claims under the European regulation on nutrition and health claims​ refer to children's development or health or to the reduction of disease risk.

EFSA’s dietetic products, nutrition and allergies (NDA) panel has so far received 268 applications, 103 applications of which were withdrawn.

To date 75 article 14 scientific opinions have been adopted.

Related topics: Regulation & Policy

Related news

Show more

Follow us

Featured Events

View more

Products

View more

Webinars